In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Fortive’s current price exceeds its PERT-weighted fair value by 7.2%, indicating potential overvaluation amid mixed valuation methods and moderate confidence. Financial health scores reveal fair profitability but weaker liquidity and growth, while Monte Carlo analysis shows high volatility and 75% downside risk below the current price. This suggests elevated investment risk with a broad value range from $23 to $184.